CTSOVSNRSN• 3 Months (Normalized)
CTSO vs NRSN (Cytosorbents Corporation vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Jun 27 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+1185.34%
Cytosorbents Corporation
Normalized Baseline0.00%
NRSN Performance $7.4
+942.25%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+243.09 pts
CTSO outperforming by 243.09 percentage points
CTSONRSN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | CTSO Price | CTSO Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $4.91 | +1185.34% | $7.40 | +942.25% | +243.09% |
| Sep 22, 2026 | $- | $7.18 | +911.27% | - | |
| Sep 21, 2026 | $5.51 | +1342.41% | $6.62 | +832.39% | +510.02% |
| Sep 18, 2026 | $5.75 | +1405.24% | $6.35 | +794.37% | +610.87% |
| Sep 17, 2026 | $5.76 | +1407.85% | $6.72 | +846.48% | +561.37% |
| Sep 16, 2026 | $5.73 | +1400.00% | $6.49 | +814.08% | +585.92% |
| Sep 15, 2026 | $6.06 | +1486.39% | $7.03 | +890.14% | +596.25% |
| Sep 14, 2026 | $6.07 | +1489.01% | $6.90 | +871.83% | +617.18% |
| Sep 11, 2026 | $6.41 | +1578.01% | $0.35 | -51.13% | +1629.14% |
| Sep 10, 2026 | $6.37 | +1567.54% | $0.33 | -53.24% | +1620.78% |
| Sep 09, 2026 | $6.33 | +1557.07% | $0.40 | -43.52% | +1600.59% |
| Sep 08, 2026 | $- | $0.42 | -41.13% | - | |
| Sep 04, 2026 | $0.35 | -8.38% | $0.51 | -28.03% | +19.65% |
| Sep 03, 2026 | $0.35 | -8.38% | $0.40 | -43.38% | +35.00% |
| Sep 02, 2026 | $0.38 | +0.52% | $0.41 | -42.11% | +42.63% |
Page 1 of 5